Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Syneron Medical Ltd (NASDAQ:ELOS)

10.32
Delayed Data
As of Jul 31
 -0.02 / -0.19%
Today’s Change
8.32
Today|||52-Week Range
12.90
+10.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues228.3M263.6M256.9M255.8M
 
 
 
 
 
Cost of Goods Sold103.4M116.2M116.4M111.5M
 
 
 
 
 
Depreciation And Amortization10.0M11.0M10.5M8.3M
 
 
 
 
 
 
Operating ExpensesGross Income114.8M136.4M130.1M136.0M
 
 
 
 
 
General Expenses131.5M141.9M140.8M133.7M
 
 
 
 
 
Other Operating Expenses528.0K105.0K0.000.00
 
 
 
Research And Development28.3M29.9M30.0M24.6M
 
 
 
 
 
Total Operating Expenses245.5M269.2M267.7M253.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.2M-5.6M-10.7M2.3M
 
 
 
 
 
Extraordinary Credit8.8M1.8M--3.0M
 
 
 
 
Extraordinary Charge-40.5M-4.0M-2.5M-7.5M
 
 
 
 
 
Interest Expense On Debt274.0K272.0K254.0K0.00
 
 
 
 
Other Expenses-554.0K-290.0K7.1M-1.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-47.8M-6.8M-6.1M-2.9M
 
 
 
 
 
Income Taxes-3.9M-4.5M-7.6M-2.3M
 
 
 
 
 
Minority Interest-955.0K-998.0K-100.0K0.00
 
 
 
 
Net Income-50.8M-1.3M1.6M-5.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS35.2M35.5M35.9M36.7M
 
 
 
 
 
Shares To Calculate EPS Diluted35.2M35.5M36.2M36.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.44-$0.04$0.04-$0.14
 
 
 
 
 
EPS Diluted-$1.44-$0.04$0.05-$0.14